Riccardo Marvulli

Papers

1

Total Citations

2

H-Index

1

About

Riccardo Marvulli is a leading researcher in pediatric neurorehabilitation, with a primary focus on the management of spasticity in children with cerebral palsy. His major contributions center on optimizing therapeutic outcomes by integrating pharmacological interventions with rehabilitative strategies. In his highly cited 2024 scope review, "Effectiveness of Integrating Botulinum Toxin Type A with Rehabilitative Strategies for Managing Spastic Diplegia in Children," Marvulli systematically analyzed multiple studies to demonstrate that combining botulinum toxin type A (BONT-A) with targeted physical and occupational therapies yields significant reductions in spasticity and marked improvements in gait and functional mobility. This work has garnered 2 citations in its first year, signaling its growing influence in clinical practice. Marvulli’s research bridges the gap between medical treatment and rehabilitation, providing evidence-based protocols that enhance quality of life for pediatric patients. His findings are particularly notable for establishing standardized integration approaches, making him a key voice in advancing multidisciplinary care for children with spastic diplegia.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Effectiveness of Integrating Botulinum Toxin Type A with Rehabilitative Strategies for Managing Spastic Diplegia in Children: Scope Review
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 8

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago